Fluoxetine/Naltrexone

氟西汀/纳曲酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFluoxetine/Naltrexone
Drug Alias Name纳曲酮氟西汀Naltrexone+Fluoxetine氟西汀+纳曲酮Fluoxetine+Naltrexone氟西汀纳曲酮 +[9] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin transporter inhibitorsMu opioid receptor antagonists
TargetsSerotonin transporterMu opioid receptor
Therapy Area/IndicationsObsessive-Compulsive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Fluoxetine hydrochlorideNaltrexone Hydrochloride
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrexigen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrexigen
Active IndicationsN/A
Inactive IndicationsObsessive-Compulsive Disorder

Other Information

ATC CodeN/A
Related LinksN/A